Bullet flag-united-kingdom flag-ireland

THIS WEBSITE IS INTENDED FOR HEALTHCARE PROFESSIONALS IN THE UK & IRELAND*

  • COVID-19
  • Respiratory

Airways Management in the COVID-19 Patient – Can Proning Help?

During this webinar, Dr Omar Usmani provides an overview of the physiology and pathophysiology of the large and small airways in patients with asthma and COPD, and the interplay between pre-existing asthma or COPD with COVID-19. He refers to the most recent guidance around use of asthma and COPD treatments and their impact on COVID-19 outcomes.

Proning is a topic that generated a lot of media attention at the start of the COVID-19 pandemic. In the second half of this webinar, Dr Suveer Singh discusses its role outside the ITU setting, with a focus on whether or not this has any benefit for patients with COVID-19. Key studies and data surrounding the hypothesis are explained covering the underlying physiological mechanisms and markers that could be used as predictors of response.

We hope that you found the content valuable. To ensure that we continue to provide topics and content of interest, we would very much value your feedback by completing a short questionnaire.

Faculty

Dr Omar Usmani

Dr Usmani is Reader and Consultant Physician in Respiratory Medicine at the National Heart and Lung Institute (NHLI), Imperial College London and Royal Brompton Hospital. He qualified in Medicine at King’s College London and completed his PhD at Imperial College London, for which he received the 2005 NHLI Imperial College PhD Prize for the best thesis. Omar’s previous research themes are Inhaled Drug Delivery, Airways Physiology, Lung Imaging, Respiratory Pharmacology and Tele-monitoring / E-health.

He is currently Co-investigator and Lead Clinical PI, on an EU HORIZON 2020 grant, investigating the role of Tele-monitoring and E-health in asthma self-management, as well as Secretary [and Head-elect] of Assembly 5 (Airway Diseases, Asthma and COPD) at the ERS, Vice President of Scientific Outputs of REG (Respiratory Effectiveness Group), Chair of UKIG (UK Inhaler Group), Vice-Chair of Drug Delivery to the Lungs (DDL), and former Europe Liaison Officer of the International Society of Aerosols in Research (ISAM).

In 2015, Omar received one of the highest accolades in aerosol science, the Thomas T Mercer Award from the American Association of Aerosol Research (AAAR) and ISAM, recognising his international research excellence in pharmaceutical aerosols and inhalable materials. In 2019, he was awarded the Fellowship of The European Respiratory Society (FERS).

Dr Suveer Singh

Dr Singh is a Consultant in Respiratory, and Critical Care Medicine at the Royal Brompton and the Chelsea and Westminster NHS Foundation Trusts, London, and also Honorary Senior Clinical Lecturer at Imperial College, London. He is an experienced specialist in respiratory critical care, severe acute respiratory failure, ECMO, ventilation and acute respiratory infection.

Clinical and research interests include early diagnostic markers for ventilator associated pneumonia and burns inhalation injury, bronchoscopy, respiratory infection and post intensive care disorders. Suveer qualified from Guy’s and St Thomas’ Medical School, with postgraduate training at Guy’s, Royal Brompton, King’s College, Chelsea and Westminster and Hammersmith Hospitals, London, with 18 years of Consultant experience in respiratory, cardiac, and burns intensive care. He was the founding director of the Bronchoscopy for Intensive Care (BrIC) national training course and the lead for sleep/ventilation.

Suveer is Director of Clinical Studies for undergraduate medicine and a former Secretary of the British Thoracic Society Interventional Pulmonology Special Advisory Group, NICE representative for Asthma Guidelines, and Faculty of the International Advanced Bronchoscopy Course at the Royal Brompton Hospital. He is a prominent Clinical Teacher, achieving the Imperial NHS Teacher’s award in 2013, and an active clinical researcher as a principal and co-investigator for multicentre trials of early diagnostic markers in pulmonary infection and sepsis. Suveer has published over 100 peer reviewed articles and supervises PhD and MD Fellows involved in academic research within Critical Care and Respiratory Medicine.

Most recently, he is editor of the forthcoming Oxford textbook of Respiratory Critical Care, and Respiratory Section editor and Editorial Board member of Medicine International, an Associate editor of Respiration, and a reviewer for several international Intensive Care and Respiratory journals.